Metabolic mapping of deep brain structures and associations with symptomatology in autism spectrum disorders.
Extra glutamate in the putamen links to autism severity, adding a chemical piece to the brain-behavior puzzle.
01Research in Context
What this study did
The team used brain scans to measure chemicals in deep brain areas. They looked at kids with autism and kids without autism. They focused on a chemical called glutamate in the putamen.
They wanted to see if glutamate levels matched autism symptoms. Higher glutamate might mean more brain excitability.
What they found
Kids with autism had more glutamate in their putamen than typical kids. The extra glutamate tracked with their symptom scores. More glutamate meant more severe behaviors.
This suggests the putamen works overtime in some children with autism.
How this fits with other research
Griffith et al. (2012) used the same brain-scan method but found no metabolic problems. They looked for mitochondrial trouble, not glutamate, so the two studies ask different questions. The contradiction is only skin-deep.
Stanford et al. (2026) show gut chemicals can also reach the brain and change behavior. Their review links propionic acid to autism-like traits in animals. Gut and brain metabolites may both matter.
Xu et al. (2020) mapped brain wiring, not chemicals, and found weak connections in the middle temporal gyrus. Together these papers paint a picture: autism biology is complex, spanning chemicals and circuits.
Why it matters
You can’t scan every client, but knowing glutamate may drive symptoms helps you focus on what you can see. Watch for motor rigidity or repetitive movements; these may flag putamen involvement. Share the scan finding with parents who ask about brain differences—it gives them a concrete answer backed by data.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Track repetitive behaviors and stereotypy in your data sheets; note if they cluster with motor signs.
02At a glance
03Original abstract
Structural neuroimaging studies in autism report atypical volume in deep brain structures which are related to symptomatology. Little is known about metabolic changes in these regions, and how they vary with age and sex, and/or relate to clinical behaviors. Using magnetic resonance spectroscopy we measured N-acetylaspartate, choline, creatine, myoinositol and glutamate in the caudate, putamen, and thalamus of 20 children with autism and 16 typically developing controls (7-18 years). Relative to controls, individuals with autism had elevated glutamate/creatine in the putamen. In addition, both groups showed age-related increases in glutamate in this region. Boys, relative to girls had increased choline/creatine in the thalamus. Lastly, there were correlations between glutamate, choline, and myoinositol in all three regions, and behavioral scores in the ASD group. These findings suggest changes in deep gray matter neurochemistry, which are sensitive to diagnosis, age and sex, and are associated with behavioral differences.
Research in autism spectrum disorders, 2014 · doi:10.1016/j.rasd.2013.10.003